Construction and validation of a survival prognostic model for stage III hepatocellular carcinoma: a real-world, multicenter clinical study

被引：0
|
作者：
Shuai Hao
Rongkun Luo
Wei Li
Ruhan Zhao
Tong Qi
Zichen Wang
Nan Li
Ming Liu
机构：
[1] The Third Hospital of Hebei Medical University,Department of Oncology
[2] Graduate School of Hebei Medical University,Department of Hepatobiliary and Pancreatic Surgery
[3] Third Xiangya Hospital,undefined
[4] Central South University,undefined
[5] Xiangya School of Medicine,undefined
[6] Central South University,undefined
来源：
BMC Gastroenterology | / 23卷
关键词：
Hepatocellular carcinoma (HCC); Nomogram; Overall survival(OS); Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Construction and Validation of a Metastasis-Related Prognostic Model for Hepatocellular Carcinoma Patients
    Liu Y.
    Xiong R.
    Xiao T.
    Yang Y.
    Liu K.
    Feng G.
    Song G.
    Dianzi Keji Daxue Xuebao/Journal of the University of Electronic Science and Technology of China, 2022, 51 (02): : 184 - 193
  • [32] PROGNOSTIC RELEVANCE OF STAGE MIGRATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA: A MULTICENTER COHORT STUDY
    Vitale, A.
    Farinati, F.
    Polacco, M.
    Trevisani, F.
    Cillo, U.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E9 - E9
  • [33] Construction and validation of an immune-related LncRNA prognostic model for hepatocellular carcinoma
    Xin, Chang
    Huang, Bin
    Chen, Mingliang
    Yan, Huanjun
    Zhu, Kelei
    Chen, Lei
    Jiang, Cunbing
    Zhang, Jianlei
    Wu, Yifeng
    CYTOKINE, 2022, 156
  • [34] Real-world Survival with CRT plus durvalumab for Unresectable, Stage III NSCLC in Canada: the RELEVANCE Study
    Wheatley-Price, P.
    Navani, V.
    Pabani, A.
    Routy, B.
    Snow, S.
    Denault, M. -H.
    Kim, Y.
    Syed, I.
    Devost, N.
    Hui, D.
    Arora, P.
    Velummailum, R.
    Springford, A.
    McKibbon, C.
    Ho, C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S159 - S159
  • [35] Long-Term Survival of Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in Real-World Clinical Practice
    Furuse, Junji
    Izumi, Namiki
    Motomura, Kenta
    Inaba, Yoshitaka
    Katamura, Yoshio
    Kondo, Yasuteru
    Yabushita, Kazuhisa
    Matsuoka, Toshiyuki
    Motoyoshi, Katsuaki
    Kudo, Masatoshi
    CANCERS, 2025, 17 (03)
  • [36] Development and external validation of a quantitative diagnostic model for malignant gastric lesions in clinical opportunistic screening: A multicenter real-world study
    Zheng Hongchen
    Liu Zhen
    Chen Yun
    Ji Ping
    Fang Zhengyu
    He Yujie
    Guo Chuanhai
    Xiao Ping
    Wang Chengwen
    Yin Weihua
    Li Fenglei
    Chen Xiujian
    Liu Mengfei
    Pan Yaqi
    Liu Fangfang
    Liu Ying
    He Zhonghu
    Ke Yang
    中华医学杂志英文版, 2024, 137 (19)
  • [37] ANALYSIS OF FACTORS RELATED TO THE TOLERABILITY OF LENVATINIB FOR PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA IN REAL-WORLD CONDITIONS: A MULTICENTER STUDY
    Taniki, Nobuhito
    Nakamoto, Nobuhiro
    Chu, Po-Sung
    Shiba, Shunsuke
    Tahara, Toshiyuki
    Komatsu, Hirokazu
    Okamura, Yukishige
    Ojiro, Keisuke
    Kikuchi, Masahiro
    Aoki, Yu
    Yamaguchi, Akihiro
    Usui, Shingo
    Kanai, Takanori
    HEPATOLOGY, 2020, 72 : 689A - 689A
  • [38] Real-world systemic sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Korea
    Lee, Min Jin
    Chang, Sung Won
    Kim, Ji Hoon
    Lee, Young-Sun
    Cho, Sung Bum
    Seo, Yeon Seok
    Yim, Hyung Joon
    Hwang, Sang Youn
    Lee, Hyun Woong
    Chang, Young
    Jang, Jae Young
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (01) : 260 - 268
  • [39] Real-world systemic sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Korea
    Min Jin Lee
    Sung Won Chang
    Ji Hoon Kim
    Young-Sun Lee
    Sung Bum Cho
    Yeon Seok Seo
    Hyung Joon Yim
    Sang Youn Hwang
    Hyun Woong Lee
    Young Chang
    Jae Young Jang
    Investigational New Drugs, 2021, 39 : 260 - 268
  • [40] The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study
    Tsuchiya, Kaoru
    Kurosaki, Masayuki
    Sakamoto, Azusa
    Marusawa, Hiroyuki
    Kojima, Yuji
    Hasebe, Chitomi
    Arai, Hirotaka
    Joko, Kouji
    Kondo, Masahiko
    Tsuji, Keiji
    Sohda, Tetsuro
    Kimura, Hiroyuki
    Ogawa, Chikara
    Uchida, Yasushi
    Wada, Shuichi
    Kobashi, Haruhiko
    Furuta, Koichiro
    Shigeno, Masaya
    Kusakabe, Atsunori
    Akahane, Takehiro
    Narita, Ryoichi
    Yoshida, Hideo
    Mitsuda, Akeri
    Ide, Yasushi
    Matsushita, Tomomichi
    Izumi, Namiki
    CANCERS, 2021, 13 (11)
12345